15.07.2014 Views

+1 - Solvay

+1 - Solvay

+1 - Solvay

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

58<br />

Our employees:<br />

a priority social<br />

responsibility<br />

Protecting our<br />

employees’ health<br />

and safety has always<br />

been a major thrust<br />

of the Group’s social<br />

commitment.<br />

Efforts continue to bring our<br />

accident prevention and reduction<br />

figures into line with the best in our<br />

industry, with a 2008 objective of<br />

a Group-wide accident frequency<br />

of 1.5 per million hours, including<br />

both <strong>Solvay</strong> employees and<br />

subcontractors working on our<br />

sites. We have still some way to<br />

go to get there.<br />

Accident frequency rate *<br />

More eco-efficient<br />

products, responding<br />

to new regulations<br />

REACh: The European<br />

regulations on chemicals, adopted<br />

at the end of 2006, come into effect<br />

in 2007. The first objective is for<br />

products covered by the REACh<br />

Regulation in Europe to be preregistered<br />

by the end of 2008.<br />

The Food and Drug Administration<br />

(FDA) in the USA cited <strong>Solvay</strong><br />

Pharmaceuticals “for its exceptional<br />

performance in implementing its<br />

portal for the electronic<br />

submission of regulatory<br />

information to the FDA<br />

by internet.” Back in 2004,<br />

All Subcontractor <strong>Solvay</strong><br />

personnel personnel personnel<br />

2003 4.4 7.2 3.3<br />

2004 3.4 6.5 2.3<br />

2005 3.2 4.4 2.7<br />

2006 2.7 4.7 2.1<br />

2007 2.4 3.2 2.1<br />

* Number of accidents leading to a work stoppage of over 24 hours, by million hours worked.<br />

<strong>Solvay</strong> was one of the first<br />

companies to shift to electronic<br />

reporting of pharmacovigilance<br />

data to the regulatory bodies in the<br />

United States and to the European<br />

Medicines Agency (EMEA).<br />

The 2007 Innovation<br />

Trophies were the occasion for<br />

SolVin to honour five remarkable<br />

projects developed with customers<br />

to meet the challenges of<br />

Sustainable Development.<br />

<strong>Solvay</strong> Pharmaceuticals<br />

at Olst (Netherlands) in<br />

2007 received a Silver Medal for<br />

the new packaging of the<br />

INFLUVAC ® flu vaccine.<br />

This smaller size packaging, entirely<br />

in recyclable cardboard, saves<br />

space and energy and reduces<br />

the CO 2<br />

emissions associated with<br />

transportation and storage.<br />

<strong>Solvay</strong> remains a<br />

driving force behiind the<br />

“Vinyl 2010” voluntary<br />

commitment of all players<br />

in the European PVC industry,<br />

aimed at integrated control of the<br />

complete product life cycle.<br />

Responsible<br />

production based<br />

on more sustainable<br />

energy resources<br />

The commissioning of the<br />

new boiler at Devnya<br />

(Bulgaria), and heat<br />

production from recycled<br />

fuels or biomass, which<br />

is being introduced or is under<br />

consideration at various European<br />

sites, are contributing to this effort.<br />

A major reduction in<br />

greenhouse gases<br />

from the <strong>Solvay</strong> Indupa<br />

(Mercosur) PVC plant at<br />

Santo Andre (Brazil) has<br />

been made possible by shifting from<br />

fuel oil to natural gas as an energy<br />

source.<br />

<strong>Solvay</strong> Global Annual Report 2007

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!